An artificial neural network (AI) designed by an international team involving UCL can translate raw data from brain activity, paving the way for new discoveries and a closer integration between technology and the brain.
The study published today in eLife, co-led by the Kavli Institute for Systems Neuroscience in Trondheim and the Max Planck Institute for Human Cognitive and Brain Sciences Leipzig and funded by Wellcome and the European Research Council, shows that a convolutional neural network, a specific type of deep learning algorithm, is able to decode many different behaviors and stimuli from a wide variety of brain regions in different species, including humans.
Lead researcher Markus Frey (Kavli Institute for Systems Neuroscience), said, “Neuroscientists have been able to record larger and larger datasets from the brain but understanding the information contained in that data—reading the neural code—is still a hard problem. In most cases we don’t know what messages are being transmitted.
“We wanted to develop an automatic method to analyze raw neural data of many different types, circumventing the need to manually decipher them.”
They tested the network, called DeepInsight, on neural signals from rats exploring an open arena and found it was able to precisely predict the position, head direction, and running speed of the animals. Even without manual processing, the results were more accurate than those obtained with conventional analyses.
Senior author Professor Caswell Barry (UCL Cell & Developmental Biology), said, “Existing methods miss a lot of potential information in neural recordings because we can only decode the elements that we already understand. Our network is able to access much more of the neural code and in doing so teaches us to read some of those other elements.
“We are able to decode neural data more accurately than before, but the real advance is that the network is not constrained by existing knowledge.”
The team found that their model was able to identify new aspects of the neural code, which they show by detecting a previously unrecognized representation of head direction, encoded by interneurons in a region of the hippocampus that is among the first to show functional defects in people with Alzheimer’s disease.
Within a day of testing positive for covid-19 in June, Miranda Kelly was sick enough to be scared. At 44, with diabetes and high blood pressure, Kelly, a certified nursing assistant, was having trouble [...]
A technology developed at Vanderbilt University Medical Center has led to the discovery of an "ultra-potent" monoclonal antibody against multiple variants of SARS-CoV-2, the virus responsible for COVID-19, including the delta variant. The antibody [...]
Research has found a significant fall in levels of antibodies against SARS-CoV-2, the virus that causes COVID-19, 6 months after the second dose of the Pfizer-BioNTech vaccine. Clinical evidence also suggests that the risk [...]
Are the COVID vaccines substantially different from/inferior to other vaccines in terms of their effectiveness? The issue raised, and I'm mostly paraphrasing here, is this: Most vaccines (e.g. measles, smallpox) have efficacy defined such [...]
The EVONANO platform allows scientists to grow virtual tumors and use artificial intelligence to automatically optimize the design of nanoparticles to treat them. The ability to grow and treat virtual tumors is an [...]
Modern Approaches to Augmentation of Brain Function Available from Springer Press This book covers recent advances in neural technology that provide for enhancements for brain function. It addresses a broad range of neural phenomena [...]
Although the currently available COVID-19 vaccines are highly effective, limited manufacturing capacity and the need for cold-chain storage hinder their global distribution. A recent study tested the efficacy of a new adeno-associated virus (AAV) [...]
Fully vaccinated people were 11 times less likely to die of COVID and 10 times less likely to be hospitalized compared to the unvaccinated since highly contagious Delta became the most common variant, US [...]
The highly-infectious Delta coronavirus variant has spread to at least 174 countries worldwide, from the US to Australia, causing a surge in COVID-19 cases. The variant has mutations that help it partially escape the immune response produced by [...]
Fragile mRNA molecules used in COVID-19 vaccines can’t get into cells on their own. They owe their success to lipid nanoparticles that took decades to refine. Messenger RNA (mRNA) is having a moment. This [...]
The COVID-19 pandemic has revealed critical knowledge gaps and assumptions concerning how respiratory viruses spread between hosts. Traditionally thought to be spread mainly through large respiratory droplets produced by the coughs and sneezes of sick individuals, [...]
SARS-CoV-2 is just one of nonillions of viruses on our planet, and scientists are rapidly identifying legions of new species. Mya Breitbart has hunted novel viruses in African termite mounds, Antarctic seals and water [...]
As a team of South African researchers we have identified a new lineage of SARS-CoV-2, the virus causing COVID-19. A lineage represents a genetically distinct virus population with a common ancestor. This virus may be designated as a variant [...]